Performance of the novel Qiagen artus QS-RGQ viral load assays compared to that of the abbott realtime system with genetically diversified HIV and hepatitis C virus plasma specimens

Journal of Clinical Microbiology

Volumn 50, Issue 6, 2012, Pages 2114-2117

  Drexler, Jan Felix ^a   Reber, Ulrike ^a   Wuttkopf, Andrea ^a   Eis Hübinger, Anna Maria ^a   Drosten, Christian ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ARTICLE; ASSAY; BLOOD SAMPLING; CONTROLLED STUDY; GENE SEQUENCE; GENOTYPE; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; INTERMETHOD COMPARISON; LIMIT OF DETECTION; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STRUCTURAL GENE; VIRUS LOAD; VIRUS LOAD ASSAY;

HEPACIVIRUS; HEPATITIS C; HIV; HIV INFECTIONS; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PLASMA; VIRAL LOAD;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84862087892     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.05874-11     Document Type: Article

References (22)

1. Anonymous. 17 June 2011, posting date. Class 2 recall: COBAS® Ampli-Prep/COBAS® TaqMan® HCVtest, CE-IVD. U.S. Food and Drug Administration (FDA), Silver Spring, MD. http://www.accessdata.fda.gov/scripts/ cdrh/cfdocs/cfres/res.cfm?id=100296.
2. Anonymous. 10 August 2011, accession date. National Center for Biotechnology Information (NCBI) genotyping tool. National Center for Biotechnology Information, Bethesda, MD. http://www.ncbi.nlm.nih.gov/projects/ genotyping/formpage.cgi.
3. Anonymous. 10 August 2011, accession date. Stanford University HIV drug resistance database. Stanford University, Stanford, CA. http://hivdb.stanford. edu.
4. Anonymous. 10 August 2011, accession date. HCV-Panel (Genotypisierung). Department of Virology, University of Duisburg, Essen, Germany. http://www.uni-due.de/virologie/HCV-Panel.html.
5. Anonymous. 2004. Verbot der Verwendung des HPS COBAS TaqMan HCV test (Roche Diagnostics GmbH, 68298 Mannheim) bei der Herstellung von zellulären Blutkomponenten und gefrorenem Frischplasma, p 19770. In Paul-Ehrlich-Institut (ed), Bundesanzeiger nr. 166. Paul-Ehrlich-Institut, Langen, Germany.
6. Beld M, et al. 2002. Performance of the new Bayer VERSANT HCV RNA 3.0 assay for quantitation of hepatitis C virus RNA in plasma and serum: conversion to international units and comparison with the Roche COBAS Amplicor HCV Monitor, version 2.0, assay. J. Clin. Microbiol. 40:788-793. (Pubitemid 34208624)
7. Chevaliez S, Bouvier-Alias M, Brillet R, Pawlotsky JM. 2007. Overestimation and underestimation of hepatitis C virus RNA levels in a widely used real-time polymerase chain reaction-based method. Hepatology 46:22-31. (Pubitemid 47171917)
8. Drexler JF, et al. 2007. Rates of and reasons for failure of commercial human immunodeficiency virus type 1 viral load assays in Brazil. J. Clin. Microbiol. 45:2061-2063. (Pubitemid 46933963)
9. Drexler JF, et al. 2009. A novel diagnostic target in the hepatitis C virus genome. PLoS Med. 6:e31. doi:10.1371/journal.pmed.1000031.
10. Fiscus SA, et al. 2006. HIV-1 viral load assays for resource-limited settings. PLoS Med. 3:e417. doi:10.1371/journal.pmed.0030417.
11. Gelderblom HC, Menting S, Beld MG. 2006. Clinical performance of the new Roche COBAS TaqMan HCV test and High Pure system for extraction, detection and quantitation of HCV RNA in plasma and serum. Antivir. Ther. 11:95-103.
12. Gueudin M, et al. 2007. Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes. J. Acquir. Immune Defic. Syndr. 44:500-505. (Pubitemid 46594892)
13. Lee SC, et al. 2000. Improved version 2.0 qualitative and quantitative AMPLICOR reverse transcription-PCR tests for hepatitis C virus RNA: calibration to international units, enhanced genotype reactivity, and performance characteristics. J. Clin. Microbiol. 38:4171-4179. (Pubitemid 32233222)
14. Murphy DG, et al. 2007. Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5= untranslated region sequences. J. Clin. Microbiol. 45:1102-1112. (Pubitemid 46626471)
15. Preiser W, Drexler JF, Drosten C. 2006. HIV-1 viral load assays for resource-limited settings: clades matter. PLoS Med. 3:e538 (doi:10.1371/journal. pmed.0030538); author reply, e550.
16. Schutten M, et al. 2007. Multicenter evaluation of the new Abbott Real- Time assays for quantitative detection of human immunodeficiency virus type 1 and hepatitis C virus RNA. J. Clin. Microbiol. 45:1712-1717. (Pubitemid 46933896)
17. Stramer SL, et al. 2004. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N. Engl. J. Med. 351:760-768.
18. Terrault NA, et al. 2005. Clinical utility of viral load measurements in individuals with chronic hepatitis C infection on antiviral therapy. J. Viral Hepat. 12:465-472. (Pubitemid 41224249)
19. Thompson MA, et al. 2010. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA Panel. JAMA 304:321-333.
20. Tuaillon E, et al. 2007. Impact of hepatitis C virus (HCV) genotypes on quantification of HCV RNA in serum by COBAS AmpliPrep/ COBAS TaqMan HCV test, Abbott antiretroviral therapy HCV Real-Time assay, and VERSANT HCV RNA assay. J. Clin. Microbiol. 45:3077-3081. (Pubitemid 47417360)
21. van Rensburg EJ, Tait K, Watt A, Schall R. 2011. Comparative evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 version 2 test using the TaqMan 48 analyzer and the Abbott RealTime HIV-1 assay. J. Clin. Microbiol. 49:377-379.
22. Wang S, Xu F, Demirci U. 2010. Advances in developing HIV-1 viral load assays for resource-limited settings. Biotechnol. Adv. 28:770-781.